Feelnor 35 MR Tablet

About Feelnor 35 MR Tablet

Feelnor 35 MR is a tablet from Incepta Pharmaceuticals Ltd., with the generic name Trimetazidine Dihydrochloride. Feelnor 35 MR is not a curative treatment for angina attacks, not an initial treatment for unstable angina pectoris, and not a treatment for myocardial infarction.

There are 13 brands of Trimetazidine Dihydrochloride listed in Bangladesh. The lowest listed price is Feelnor 20 mg Tablet at ৳ 3 per unit.

What is Feelnor 35 MR Tablet?

Made by Incepta Pharmaceuticals Ltd., Feelnor 35 MR is a tablet whose active ingredient is Trimetazidine Dihydrochloride. Its active substance is Trimetazidine Dihydrochloride, which belongs to a group of metabolic anti-ischaemic and anti-anginal medicines. Feelnor 35 MR does not treat angina attacks or act as an initial treatment for unstable angina, and it is not a treatment for myocardial infarction. Whether it suits you is a decision for your doctor.

Uses of Feelnor 35 MR

Feelnor 35 MR is not a curative treatment for angina attacks, not an initial treatment for unstable angina pectoris, and not a treatment for myocardial infarction. Feelnor 35 MR is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated. Ask the doctor if you are unsure why it has been prescribed for you. Your doctor will decide if it is suitable for you.

How to use Feelnor 35 MR

Swallow the tablet as your doctor or pharmacist advises. Feelnor 35 MR is taken by mouth. Swallow the tablet with water. Take Feelnor 35 MR exactly as prescribed by your doctor. The doctor decides the dose and how long you take it, and may assess the benefit after a period of treatment. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than adjusting the schedule on your own.

Side effects of Feelnor 35 MR

Do not decide on your own to stop or change the medicine; the doctor will advise what to do. Seek medical advice promptly if you develop a serious or unexpected reaction. If any side effect troubles you or does not settle, contact your doctor or pharmacist. Ask your doctor or pharmacist about anything you are worried about. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. Feelnor 35 MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction. Avoid it during pregnancy and breast-feeding. Tell your doctor if you are pregnant, planning pregnancy or breast-feeding, and ask a doctor first if you have kidney problems or movement symptoms.

Frequently asked questions

What does Feelnor 35 MR treat?

Feelnor 35 MR is not a curative treatment for angina attacks, not an initial treatment for unstable angina pectoris, and not a treatment for myocardial infarction. Feelnor 35 MR is used in adults alongside other medicines for the symptomatic treatment of stable angina pectoris, when first-line anti-anginal therapies are not adequate or are not tolerated.

How do I use Feelnor 35 MR correctly?

Swallow the tablet as your doctor or pharmacist advises. Feelnor 35 MR is taken by mouth.

Can Feelnor 35 MR cause side effects?

Do not decide on your own to stop or change the medicine; the doctor will advise what to do. Seek medical advice promptly if you develop a serious or unexpected reaction.

Can I use Feelnor 35 MR in pregnancy or while breastfeeding?

It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. Feelnor 35 MR is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris, and it is not a treatment for myocardial infarction.

Indications

Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

Pharmacology

Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.

Dosage & Administration

The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.

Interaction

No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.

Contraindications

Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.

Side Effects

Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia

Pregnancy & Lactation

There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.

Precautions & Warnings

Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Alternative brands of Trimetazidine Dihydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.